Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)
Article first published online: 5 MAR 2007
2007, IGCS and ESGO
International Journal of Gynecological Cancer
Volume 17, Issue 4, pages 784–788, July/August 2007
How to Cite
ALBERTS, D.S., LIU, P.Y., WILCZYNSKI, S.P., JANG, A., MOON, J., WARD, J.H., BECK, J.T., CLOUSER, M. and MARKMAN, M. (2007), Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211). International Journal of Gynecological Cancer, 17: 784–788. doi: 10.1111/j.1525-1438.2007.00882.x
- Issue published online: 13 JUL 2007
- Article first published online: 5 MAR 2007
- Accepted for publication December 19, 2006
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!